Posted 5th January 2026
Posted 2 weeks ago
By NHP Office
NHP Cellular Therapy Operational Group (CTG)
Learn more about the NHP Cellular Therapy Operational Group (CTG)
Posted 5th January 2026
Posted 31st August 2025
Posted 5 months ago
By NHP Office
20250831 RCPath National Examiner's Good Practice in Sickle Cell Disease
The guidance provides good practice advice for medical examiners on recognising the impact of SCD in various contexts including deaths and coroner referrals.
Posted 11th August 2025
Posted 5 months ago
By NHP Office
Mortality Reporting Pathway
First iteration of the mortality reporting pathway for haemoglobinopathies.
Posted 9th September 2024
Posted 1 year ago
By NHS England
SOP- Casgevy (Exagamglogene Autotemcel) for Transfusion-dependent Thalassaemia
University College London have produced a Standard Operating Procedure (SOP) for the assessment and work up of exagamglogene autotemcel (Casgevy™) for transfusion-dependent beta-thalassaemia
